Preconditioning Reprograms the Response to Ischemic Injury and Primes the Emergence of Unique Endogenous Neuroprotective Phenotypes: A Speculative Synthesis
Abstract
Ischemic tolerance in the brain, in which sub-threshold insults increase resistance to subsequent injurious ischemia, is a powerful adaptive defense that involves an endogenous program of neuroprotection. Emerging evidence from genomic studies suggests diverse stimuli that trigger preconditioning achieve neuroprotection through a common process which depends on a fundamental reprogramming of the response to injury. Such reprogramming of the genomic response to injury leads to the induction of novel neuroprotective pathways not ordinarily found in the setting of ischemia. Genomic studies also indicate that the nature of the preconditioning stimulus (eg, brief ischemia or endotoxin [lipopolysaccharide]) dictates the phenotype of neuroprotection, a phenotype that parallels protective adaptations also found in certain physiological conditions where the preconditioning stimulus exists at levels that can induce injury. The idea that preconditioning leads to a fundamental reprogramming event that confers neuroprotection is a novel and important concept in the field of ischemic tolerance. Moreover, the view that distinct preconditioning stimuli confer neuroprotection via effectors that differ according to the nature of the preconditioning stimulus offers promise that multiple, nonoverlapping pathways may be discovered as novel neuroprotective therapies.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The relatively short occlusion times used may act as preconditioning signals that by themselves cause little neuronal loss, but protect against cell death after subsequent challenge with longer ischemia.
“The relatively short occlusion times we used may also act as preconditioning signals that by themselves cause little neuronal loss, but protect against cell death after subsequent challenge with longer ischemia (Gidday, 2006;Stenzel-Poore et al., 2007).”
From Two-Photon Imaging of Stroke Onset<i>In Vivo</i>Reveals That NMDA-Receptor Independent Ischemic Depolarization Is the Major Cause of Rapid Reversible Damage to Dendrites and Spines (2008) · cites this paper as Stenzel-Poore et al., 2007
Cites
Toll-like receptors in innate immunity
Takeda, K. (2004) · International Immunology · doi:10.1093/intimm/dxh186 · Cited by 3,328 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
A new penumbra: transitioning from injury into repair after stroke
Lo, E. H. (2008) · Nature Medicine · doi:10.1038/nm1735 · Cited by 611 · see citing works
Murphy, T. H., Li, P., Betts, K., & Liu, R. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.5128-07.2008 · Cited by 261 · see citing works
“The relatively short occlusion times we used may also act as preconditioning signals that by themselves cause little neuronal loss, but protect against cell death after subsequent challenge with longer ischemia (Gidday, 2006; Stenzel-Poore et al., 2007).”
BackgroundLi, P., & Murphy, T. H. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.3724-08.2008 · Cited by 120 · see citing works
Pusic, K. M., Pusic, A. D., Kemme, J., & Kraig, R. P. (2014) · Glia · doi:10.1002/glia.22672 · Cited by 85 · see citing works
- Authors
- Stenzel-Poore, M. P., Stevens, S. L., King, J. S., & Simon, R. P.
- Affiliations
- From Department of Molecular Microbiology and Immunology (M.P.S.-P., S.L.S.), Oregon Health & Science University, Portland, Ore; NeuroProtect, Inc. (J.S.K.), Portland, Ore; Robert S. Dow Neurobiology Laboratories (R.P.S.), Legacy Research, Portland, Ore.
- Legacy Health (US)
- ORCID
- Simon, Roger P.
- Venue
- Stroke
- Published
- 2007-02
- Volume
- 38
- Issue
- 2
- Pages
- 680-685
- ISSN
- 0039-2499 (ISSN-L)
- 1524-4628
- OpenAlex
- W2038707186
- Cited by
- 192
- References
- 1
- Citations by year
- 2026: 1 · 2025: 1 · 2024: 6 · 2023: 4 · 2022: 2 · 2021: 6 · 2020: 7 · 2019: 4 · 2018: 5 · 2017: 8 · 2016: 9 · 2015: 18 · 2014: 14 · 2013: 14 · 2012: 20
- FWCI
- 1.75
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Stroke (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5r01ns050567-10)
- National Institute of Neurological Disorders and Stroke (NS046827, NS 35965, P01NS035965, NS50567)
- Topics
- Life Sciences › Neuroscience › Neurology › Neurological Disorders and Treatments
- Health Sciences › Medicine › Pathology and Forensic Medicine › Cardiac Ischemia and Reperfusion
- Health Sciences › Medicine › Epidemiology › Acute Ischemic Stroke Management
- Keywords
- ischemic preconditioning, ischemic tolerance, neuroprotection, cerebral ischemia, endotoxin, lipopolysaccharide
- MeSH terms
- Animals, Brain Ischemia, Humans, Phenotype, Ischemic Preconditioning
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review